Target intelligence / Profile preview

Cytochrome bc1 complex (Mitochondrial Complex III) (Complex III)

Target
Complex III
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial respiratory chain complex
01

Overview

Mitochondrial Complex III, also known as the cytochrome bc1 complex, is a central component of the electron transport chain responsible for transferring electrons from ubiquinol to cytochrome c [16, 18]. This process is coupled to proton translocation across the inner mitochondrial membrane, creating the electrochemical gradient necessary for ATP synthesis via the Q-cycle [16]. The complex contains two distinct quinone-binding sites: the Qo site (outer, ubiquinol oxidation) and the Qi site (inner, ubiquinone reduction) [18]. These sites are critical therapeutic targets; for instance, the Qo site is targeted by the antimalarial drug atovaquone, while the Qi site is inhibited by compounds like antimycin A [1, 3, 6]. Beyond energy production, Complex III is a major source of cellular reactive oxygen species (ROS) and plays a key role in hypoxic signaling through the stabilization of HIF-1alpha [19, 22]. Dysregulation or inhibition of these sites is linked to various conditions, including parasitic infections, mitochondrial myopathies, and cancer progression [6, 10, 12]. In parasites like Plasmodium, inhibition of this complex also disrupts pyrimidine biosynthesis, which is essential for survival [13].

Other names
Ubiquinol-cytochrome c reductaseCoenzyme Q-cytochrome c reductasebc1 complexQo siteQi siteUbiquinol oxidation siteUbiquinone reduction site
02

Mechanism of action

Inhibition of the Q-cycle by binding to the Qo or Qi sites, blocking electron transfer from ubiquinol to cytochrome c [16]. This disruption halts the generation of the proton motive force required for ATP synthesis and leads to the accumulation of electrons on upstream carriers, promoting the generation of reactive oxygen species (ROS) such as superoxide [1, 4, 21].

03

Biological functions

Electron transportATP synthesisReactive oxygen species generationHypoxic signalingProton translocation
04

Disease associations

InfectionMalariaCancerMitochondrial diseaseNeurodegenerative disease
05

Safety considerations

Mitochondrial toxicity in host tissuesCross-reactivity between parasite and human enzymesRapid emergence of resistance mutationsOxidative stress-induced cellular damage
06

Interacting drugs

Atovaquone

6 more in the full profile.

07

Biomarkers

Reactive oxygen species (ROS) levelsOxygen consumption rate (OCR)ATP levelsHIF-1alpha stabilization

Beyond the preview

Go deeper on Cytochrome bc1 complex (Mitochondrial Complex III) (Complex III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome bc1 complex (Mitochondrial Complex III) (Complex III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call